Today is 20th March and it was this day in 2009 when the new form of Right to Information Act (RTI Act) was enacted in J&K by Omar Abdullah led Government soon after coming to power. Prior to 2009 we had an RTI law passed by PDP Congress coalition Government headed by Mufti Mohammad Syeed in 2004 (J&K RTI Act 2004). The 2004 version of RTI Act was much weaker...
More »SEARCH RESULT
Natco gets India’s first compulsory licence-CH Unnikrishnan
In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...
More »India's patent ruling on cancer may open door for cheaper HIV drugs
-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »'Adani forcing farmers to vacate land'
-The Times of India Instead of creating happiness in the lives of farmers in adjacent villages, Adani power corporation has rendered them landless as their agricultural land is forcibly acquired by the district administration for requirement of the thermal power company. Once affluent, these farmers have now come below poverty line. Adani Thermal Power Corporation has acquired agricultural land in and around it's thermal power plant near Tiroda (Gondia). The state government gave...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »